2 Top Biotech Stocks to Buy in February
These days, the real economy and the stock market seem to be in stark contrast to one another. While the annual U.S. real gross domestic product (GDP) growth rate has improved since the lows reported in June 2020, it's still far from from positive territory. Yet, the stock market is not reflecting the state of the economy, and has been busy reaching new highs. Some market experts fear that the stock market is in bubble phase and may soon crash, while some others believe that the upcoming coronavirus stimulus can take the market even higher.
Whatever be the outcome, biotech stocks such as Novavax (NASDAQ: NVAX) and Gamida Cell (NASDAQ: GMDA) will mostly remain unaffected and continue their robust growth trajectory in 2021 -- especially given recent positive news surrounding both of their businesses.
Image Source: Getty Images
Source Fool.com
